Shanna Miranti, MPAS, PA-C: Assessing Treatment Efficacy in Patients with Vitiligo
![](https://jcad.tv/wp-content/uploads/2024/04/Shanna-Miranti-EP-Still-1024x576.jpg)
Shanna Miranti, MPAS, PA-C, discusses the similar efficacy seen in patients treated with ruxolitinib at diagnosis versus those who had disease for years.
Shanna Miranti, MPAS, PA-C: Managing the Psychosocial Impact of Vitiligo
![](https://jcad.tv/wp-content/uploads/2024/04/Shanna-Miranti-EP-Still-1024x576.jpg)
Shanna Miranti, MPAS, PA-C, discusses the bimodal distribution of vitiligo in male and female individuals and the necessary counseling for those who are managing their initial diagnosis.
Andrea Nguyen, PA-C, MS: Determining Treatment Goals and Expectations for Patients with Vitiligo
![](https://jcad.tv/wp-content/uploads/2024/02/Andrea-Nguyen-Thumbnail-1024x576.jpg)
Andrea Nguyen discusses how she counsels patients with vitiligo and emphasizes the importance in communicating with patients about consistent application and dosing during a treatment regimen.
Raj Chovatiya, MD, PhD: Utilizing Ruxolitinib Cream for Patients with Vitiligo
![](https://jcad.tv/wp-content/uploads/2023/09/Chovatiya-NPPA-Fall-2023-Thumbnail-1024x576.jpg)
Dr. Chovatiya discusses how to effectively treat patients with nonsegmental vitiligo using topical ruxolitinib cream and the importance in a slow and steady treatment regimen.
Nada Elbuluk, MD, FAAD: Research and Utility of Ruxolitinib Cream for Vitiligo
![](https://jcad.tv/wp-content/uploads/2023/06/Nada-Elbuluk-Thumbnail-v2-1024x576.jpg)
Dr. Elbuluk discusses results of the clinical trials for ruxolitinib cream in patients with vitiligo and how this treatment is being incorporated into the dermatologist’s vitiligo toolkit.